Cullinan Therapeutics, Inc. (CGEM)
(Delayed Data from NSDQ)
$19.60 USD
+0.74 (3.92%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $19.42 -0.18 (-0.92%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.78 | -1.07% |
Earnings Summary
For their last quarter, Cullinan Therapeutics, Inc. (CGEM) reported earnings of -$0.75 per share, missing the Zacks Consensus Estimate of -$0.73 per share. This reflects a negative earnings surprise of 2.74%. Look out for CGEM's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 14.29%.
Earnings History
Price & Consensus
Zacks News for CGEM
Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
CGEM: What are Zacks experts saying now?
Zacks Private Portfolio Services